Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE: IVIg for Transverse Myelitis
NCT02398994Phase 3Terminated
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in transverse myelitis (TM), neuromyelitis optica (NMO), sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Mar 2015; status: terminated.
02
Drugs
intravenous immunoglobulin G
03
Conditions
transverse myelitis (TM)neuromyelitis optica (NMO)
Beyond the preview
Go deeper on NCT02398994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398994.